Edition:
United Kingdom

Miragen Therapeutics Inc (MGEN.OQ)

MGEN.OQ on NASDAQ Stock Exchange Capital Market

7.55USD
13 Dec 2017
Change (% chg)

$0.18 (+2.44%)
Prev Close
$7.37
Open
$7.40
Day's High
$7.65
Day's Low
$7.36
Volume
66,257
Avg. Vol
25,705
52-wk High
$17.83
52-wk Low
$4.65

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.63 -0.270
Jun '17 0.72 -0.342
Mar '17 0.46 -0.604
FY 2016 Dec '16 0.76 -7.580
Sep '16 0.89 -2.557
Jun '16 1.12 -5.877
Mar '16 0.92 -5.583
FY 2015 Dec '15 0.66 -4.192
Sep '15 0.50 -5.819
Jun '15 0.73 -4.936
Mar '15 0.64 -6.820
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 3 1.14 1.63 0.20 --
Quarter Ending Mar-18 2 1.62 1.63 1.60 --
Year Ending Dec-17 3 3.45 4.44 1.50 --
Year Ending Dec-18 3 4.37 6.60 0.00 --
Earnings (per share)
Quarter Ending Dec-17 3 -0.32 -0.28 -0.39 --
Quarter Ending Mar-18 2 -0.31 -0.30 -0.33 --
Year Ending Dec-17 3 -1.36 -1.30 -1.41 --
Year Ending Dec-18 3 -1.43 -1.29 -1.57 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta 1.97 0.85 0.88
Price to Sales (TTM) 71.79 100.67 5.40
Price to Book (MRQ) 4.91 13.50 5.38
Price to Tangible Book (MRQ) 4.91 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 44.73 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -35.61 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -11.50 75.03 5.38
Sales - 5 Yr. Growth Rate 11.74 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 94.19 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 48.38 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -64.33 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 7.44 5.36 2.98
LT Debt to Equity (MRQ) 4.53 18.92 11.56
Total Debt to Equity (MRQ) 9.31 20.59 15.81
Interest Coverage (TTM) -59.71 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 12.53 38.73 54.83
Gross Margin - 5 Yr. Avg. 25.55 51.18 52.40
EBITD Margin (TTM) -654.94 -- --
EBITD - 5 Yr. Avg -161.55 -261.11 15.24
Operating Margin (TTM) -766.34 -556.64 7.76
Operating Margin - 5 Yr. Avg. -184.26 -279.29 10.75
Pre-Tax Margin (TTM) -768.18 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -209.71 -279.02 11.17
Net Profit Margin (TTM) -768.18 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -209.71 -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 25,314,503 864,673,362
Net Income/Employee (TTM) -- 3,332,048 101,717,513
Receivable Turnover (TTM) 4.72 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.10 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -73.48 -0.78 11.00
Return on Assets - 5 Yr. Avg. -95.81 -0.26 12.43
Return on Investment (TTM) -87.08 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -90.87 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 31.48 -8.22 11.74
EPS (TTM) % 16.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Miragen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 45.75%
# of Holders: 69
Total Shares Held: 10,207,388
3 Mo. Net Change: -1,478,300
# New Positions: 15
# Closed Positions: 4
# Increased Positions: 36
# Reduced Positions: 15
# Net Buyers: 21
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.